On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Biohaven Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Biohaven Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Biohaven Pharmaceuticals (United States)?

ScholarIQrecord summary

Biohaven Pharmaceuticals (United States) is a research organisation in New Haven, US. OpenAlex records 409 works and 149,610 citations for it. 150 researchers list it as their most recent affiliation.

How many works does Biohaven Pharmaceuticals (United States) have?

ScholarIQindexed works

Biohaven Pharmaceuticals (United States) has 409 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Biohaven Pharmaceuticals (United States) have?

ScholarIQcitation count

Biohaven Pharmaceuticals (United States) has 149,610 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Biohaven Pharmaceuticals (United States)?

ScholarIQresearcher count

Biohaven Pharmaceuticals (United States) has 150 researchers in the ScholarIQ index.

What is the average h-index at Biohaven Pharmaceuticals (United States)?

ScholarIQavg h-index

Biohaven Pharmaceuticals (United States) has an average h-index of 34 in OpenAlex.

What is the ROR of Biohaven Pharmaceuticals (United States)?

ScholarIQror

The ROR for Biohaven Pharmaceuticals (United States) is on the source record.

What is the OpenAlex record for Biohaven Pharmaceuticals (United States)?

ScholarIQopenalex

The OpenAlex for Biohaven Pharmaceuticals (United States) is on the source record.

Who are the most-cited researchers behind Biohaven Pharmaceuticals (United States)?

ScholarIQtop researchers by citations
1
M Abraham · Protein Structure and Dynamics
38 works29,468 citations
2
Gilbert L’Italien · Migraine and Headache Studies
245 works10,539 citations
3
Vladimir Coric · Migraine and Headache Studies
166 works7,958 citations

What are the most-cited papers on Biohaven Pharmaceuticals (United States)?

ScholarIQmost cited works
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
Shaista Malik, Nathan D. Wong, Stanley S. Franklin, Tripthi Kamath, Gilbert L’Italien, Jose R. Pio, G. Rhys Williams
Circulation. 20041,852 Citations
Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey
John K. Ninomiya, Gilbert L’Italien, Michael H. Criqui, Joanna L. Whyte, Anthony Gamst, Roland S. Chen
Circulation. 2003799 Citations
Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives
Stanley S. Franklin, Milagros J. Jacobs, Nathan D. Wong, Gilbert L’Italien, Pablo Lapuerta
Hypertension. 2001706 CitationsOPEN ACCESS
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
Michael H. Bloch, Angeli Landeros‐Weisenberger, Ben Kelmendi, Vladimir Coric, Michael B. Bracken, James F. Leckman
Molecular Psychiatry. 2006625 Citations
Physician-Related Barriers to the Effective Management of Uncontrolled Hypertension
Susan A. Oliveria, Pablo Lapuerta, Bruce D. McCarthy, Gilbert L’Italien, Dan R. Berlowitz, Steven M. Asch
Archives of Internal Medicine. 2002486 Citations

How much of the research on Biohaven Pharmaceuticals (United States) is open access?

ScholarIQopen access share
25%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
25%
Closed
75%

Related on ScholarIQ

470M+ articles · 14-day free trial